ZA986480B - Therapeutic and dietary compositions - Google Patents

Therapeutic and dietary compositions

Info

Publication number: ZA986480B
Authority: ZA; South Africa
Prior art keywords: therapeutic; compositions; dietary compositions; nutrition; therapy
Prior art date: 1997-07-22

Application number

ZA986480A

Other languages

English (en)

Inventor

David Frederick Horrobin

Hans-Jurgen Tritschler

Original Assignee

Scotia Pharma Ltd

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-22

Filing date

1998-07-21

Publication date

1999-01-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA986480(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-07-21 Application filed by Scotia Pharma Ltd, Asta Medica Ag filed Critical Scotia Pharma Ltd

1999-01-22 Publication of ZA986480B publication Critical patent/ZA986480B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Hematology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

ZA986480A 1997-07-22 1998-07-21 Therapeutic and dietary compositions ZA986480B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB9715444A GB9715444D0 (en)	1997-07-22	1997-07-22	Therapeutic and dietary compositions

Publications (1)

Publication Number	Publication Date
ZA986480B true ZA986480B (en)	1999-01-22

Family

ID=10816266

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA986480A ZA986480B (en)	1997-07-22	1998-07-21	Therapeutic and dietary compositions

Country Status (30)

Country	Link
US (1)	US6630157B1 (de)
EP (2)	EP1419769A1 (de)
JP (1)	JP4476479B2 (de)
KR (1)	KR100545630B1 (de)
CN (2)	CN1679532A (de)
AT (1)	ATE262900T1 (de)
AU (1)	AU739876B2 (de)
BG (1)	BG64349B1 (de)
BR (1)	BR9812102A (de)
CA (1)	CA2297082C (de)
CZ (1)	CZ298527B6 (de)
DE (1)	DE69822832T2 (de)
DK (1)	DK0994705T3 (de)
ES (1)	ES2214717T3 (de)
GB (2)	GB9715444D0 (de)
HU (1)	HU226673B1 (de)
IL (2)	IL134090A0 (de)
MY (1)	MY127930A (de)
NO (1)	NO327173B1 (de)
NZ (1)	NZ502278A (de)
PL (1)	PL194059B1 (de)
PT (1)	PT994705E (de)
RO (1)	RO121318B1 (de)
RU (1)	RU2205004C2 (de)
SK (1)	SK285836B6 (de)
TR (1)	TR200000178T2 (de)
TW (1)	TW565444B (de)
UA (1)	UA66363C2 (de)
WO (1)	WO1999004782A1 (de)
ZA (1)	ZA986480B (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7226916B1 (en)	2000-05-08	2007-06-05	N.V. Nutricia	Preparation for the prevention and/or treatment of vascular disorders
US7208180B2 (en) *	2000-05-08	2007-04-24	N.V. Nutricia	Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
DE10027968A1 (de) *	2000-06-08	2001-12-13	Asta Medica Ag	Mittel zur Therapie von Demenzen
US20020132781A1 (en) *	2000-10-06	2002-09-19	George Kindness	Combination and method of treatment of cancer utilizing a COX-2 inhibitor and A 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA) reductase inhibitor
US8669282B2 (en) *	2000-10-31	2014-03-11	Hill's Pet Nutrition, Inc.	Companion animal compositions including lipoic acid and methods of use thereof
DE10125882B4 (de) *	2001-05-28	2007-03-29	Esparma Gmbh	Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus
NL1019368C2 (nl) *	2001-11-14	2003-05-20	Nutricia Nv	Preparaat voor het verbeteren van receptorwerking.
US6974592B2 (en) *	2002-04-11	2005-12-13	Ocean Nutrition Canada Limited	Encapsulated agglomeration of microcapsules and method for the preparation thereof
AU2003240187A1 (en) *	2002-06-17	2003-12-31	Medestea Research And Production S.R.L.	A process for preparing long chain saturated or unsaturated oxygenated compounds
EP1558237A4 (de) *	2002-09-27	2007-01-17	Martek Biosciences Corp	VERBESSERTE BLUTZUCKERKONTROLLE F RPRû-DIABETES UND/ODER DIABETES TYP II UNTER VERWENDUNG VON DOCOSAHEXAENSûURE
US20040106584A1 (en) *	2002-09-27	2004-06-03	Linda Arterburn	Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
BRPI0315977B8 (pt) *	2002-11-04	2021-05-25	Dsm Nutritional Products Ag	microcápsulas possuindo múltiplas cascas e método para preparação destas
US20060233863A1 (en)	2003-02-10	2006-10-19	Enzymotec Ltd.	Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
AU2004212004B2 (en)	2003-02-13	2008-01-10	Albert Einstein College Of Medicine Of Yeshiva University	Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus
GB0311081D0 (en) *	2003-05-14	2003-06-18	Btg Internat Limted	Treatment of neurodegenerative conditions
ATE402695T1 (de) *	2003-08-11	2008-08-15	Hills Pet Nutrition Inc	Omega-3-fettsäuren zur behandlung von osteoarthritis bei hunden
US8633247B2 (en)	2003-08-11	2014-01-21	Hill's Pet Nutrition, Inc.	Method for decreasing cartilage damage in dogs
US8633246B2 (en)	2003-08-11	2014-01-21	Hill's Pet Nutrition, Inc.	Omega-3 fatty acids for osteoarthritis
EP2324828A1 (de) *	2003-08-18	2011-05-25	BTG International Limited	Behandlung neurodegenerativer Erkrankungen
US20050261367A1 (en) *	2004-03-29	2005-11-24	Howard Murad	Methods for treating dermatological and other health-related conditions in a patient
JP5667737B2 (ja) *	2004-07-01	2015-02-12	ネステクソシエテアノニム	イヌ変形性関節症食餌製剤
CN101027318B (zh)	2004-07-19	2016-05-25	比奥孔有限公司	胰岛素-低聚物共轭物，制剂及其用途
US20090232916A1 (en) *	2004-08-09	2009-09-17	Avidor Shulman	Food products for diabetics
AU2005270831B2 (en)	2004-08-10	2011-08-25	Enzymotec Ltd.	Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
GB0425932D0 (en) *	2004-11-25	2004-12-29	Btg Int Ltd	Structured phospholipids
GB0428166D0 (en) *	2004-12-23	2005-01-26	Efamol Ltd	Use of essentially fatty acid molecules
US8034450B2 (en) *	2005-01-21	2011-10-11	Ocean Nutrition Canada Limited	Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
CA2596023A1 (en) *	2005-01-27	2006-11-09	Ocean Nutrition Canada Ltd.	Fatty acid-benzenediol derivatives and methods of making and using thereof
EP1848729A2 (de) *	2005-01-27	2007-10-31	Ocean Nutrition Canada Limited	Chrom-fettsäureverbindungen und verfahren zu ihrer herstellung und verwendung
GB0504333D0 (en) *	2005-03-02	2005-04-06	Btg Int Ltd	Treatment of cytokine dysregulation
GB0504362D0 (en) *	2005-03-02	2005-04-06	Btg Int Ltd	Cytokine modulators
US9968120B2 (en) *	2006-05-17	2018-05-15	Dsm Nutritional Products Ag	Homogenized formulations containing microcapsules and methods of making and using thereof
US20070082063A1 (en) *	2005-10-11	2007-04-12	Douglas Bibus	Risk assessment and correction of membrane damage of the upper GI tract
US20090069638A1 (en) *	2005-12-02	2009-03-12	Howard Murad	Diagnostic and Treatment Regimen for Achieving Body Water Homeostasis
US9265745B2 (en) *	2005-12-21	2016-02-23	Brudy Technology S.L.	Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
WO2007089685A2 (en) *	2006-01-30	2007-08-09	University Of Georgia Research Foundation	Compositions and methods for inducing adipose tissue cell death
MX292905B (es) *	2006-04-07	2011-12-01	Ocean Nutrition Canada Ltd	Emulsiones y microcapsulas con sustancias que tienen baja tension interfacial y metodos para fabricar y usar las mismas.
KR20090046773A (ko) *	2006-06-05	2009-05-11	오션 뉴트리션 캐나다 리미티드	개선된 쉘을 가지는 마이크로캡슐
US10166196B2 (en)	2007-01-10	2019-01-01	Dsm Nutritional Products Ag	Vegetarian microcapsules
DE102007038849A1 (de)	2007-08-16	2009-02-19	Adscil Gmbh	Verwendung von R(+)-alpha-Liponsäure zur Behandlung der kryptogenen Neuropathie
US9241908B2 (en)	2007-10-16	2016-01-26	Biocon Limited	Orally administrable solid pharmaceutical composition and a process thereof
US8343753B2 (en) *	2007-11-01	2013-01-01	Wake Forest University School Of Medicine	Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en)	2009-04-29	2009-06-10	Equateq Ltd	Novel methods
US9119826B2 (en) *	2011-02-16	2015-09-01	Pivotal Therapeutics, Inc.	Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
EP2708230B1 (de) *	2011-05-12	2024-10-02	Nissui Corporation	Zusammensetzung zur äusserlichen anwendung auf der haut für entzündliche erkrankungen
US8293790B2 (en)	2011-10-19	2012-10-23	Dignity Sciences Limited	Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2014151128A1 (en) *	2013-03-15	2014-09-25	Andrade Agustin	Composition and method for treating neuropathy
US9226914B2 (en)	2013-07-16	2016-01-05	Mead Johnson Nutrition Company	Methods for promoting neuronal development and/or health
US9241923B2 (en)	2013-07-16	2016-01-26	Mead Johnson Nutrition Company	Methods for promoting neuronal development and/or health
ES2727387T3 (es)	2013-11-15	2019-10-15	Ds Biopharma Ltd	Sal de lisina de ácido 15-hidroxi-8(Z),11(Z),13(E)-eicosatrienoico
ES2872449T3 (es)	2013-12-04	2021-11-02	Nippon Suisan Kaisha Ltd	Aceite microbiano, procedimiento para fabricar aceite microbiano, aceite microbiano concentrado y procedimiento para fabricar aceite microbiano concentrado
MX375328B (es)	2014-06-04	2025-03-06	Ds Biopharma Ltd	Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas
WO2016044167A1 (en) *	2014-09-15	2016-03-24	Abbott Laboratories	Methods for increasing muscle strength and mobility in subjects experiencing significant physical inactivity using gamma linolenic acid
US10047033B2 (en)	2015-05-13	2018-08-14	Ds Biopharma Limited	Compositions comprising oxo-derivatives of fatty acids and methods of making and using same
CN112245420A (zh)	2015-07-21	2021-01-22	艾菲穆恩有限公司	用于治疗或预防癌症和神经疾病的包括15-hepe的组合物
AU2016370626B2 (en)	2015-12-18	2020-08-20	Afimmune Limited	Compositions comprising 15-HEPE and methods of using the same
US11344497B1 (en)	2017-12-08	2022-05-31	Quicksilver Scientific, Inc.	Mitochondrial performance enhancement nanoemulsion
US10722465B1 (en)	2017-12-08	2020-07-28	Quicksilber Scientific, Inc.	Transparent colloidal vitamin supplement
US12653854B2 (en)	2019-04-15	2026-06-16	Quicksilver Scientific, Inc.	Intra-oral nanoemulsion including monolayer surfactant bound particles for balancing histamine response
US11291702B1 (en)	2019-04-15	2022-04-05	Quicksilver Scientific, Inc.	Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
WO2022140279A1 (en) *	2020-12-22	2022-06-30	Buck Institute For Research On Aging	Synergistic modulators of alpha-dicarbonyl detoxification and their use for inducing weight loss and the treatment of diabetic pathologies
CN114533715A (zh) *	2022-01-28	2022-05-27	上海市肺科医院	一种针对sting靶点的小分子抑制剂及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1176916B (it) *	1984-10-10	1987-08-18	Elvira Pistolesi	Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
GB8524275D0 (en) *	1985-10-02	1985-11-06	Efamol Ltd	Pharmaceutical & dietary compositions
LU86220A1 (de) *	1985-12-19	1987-07-24	Chimicasa Gmbh	Verfahren zur herstellung eines den cholesterin-und triglyceridgehalt senkenden pharmazeutischen praeparates
DE3615710A1 (de) *	1986-05-09	1987-11-26	Hoechst Ag	Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
US4937265A (en) *	1987-05-28	1990-06-26	Teijin Limited	Antidiabetic method comprising 7-thiaprostaglandin E1 or its derivatives
EP0382066A3 (de)	1989-02-09	1992-01-08	ASTA Medica Aktiengesellschaft	Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
UA26442C2 (uk) *	1990-08-20	1999-08-30	Герхард Оленшлегер	Фармкомпозиція для профілактики і лікуваhhя захворюваhь, пов'язаhих з порушеhhям обміhу речовиh
US5602183A (en)	1991-03-01	1997-02-11	Warner-Lambert Company	Dermatological wound healing compositions and methods for preparing and using same
US5569670A (en)	1992-06-05	1996-10-29	Asta Medica Aktiengesellschaft	Combination medications containing alpha-lipoic acid and related
DE4229914A1 (de)	1992-09-08	1994-03-10	Basf Ag	Verbessertes Verfahren zur Herstellung von R/S-Ï-Liponsäure oder R/S-â-Liponsäure
DK0661051T3 (da) *	1993-10-11	2006-05-22	Viatris Gmbh	Medikament til behandling af hypertension
US5472698A (en) *	1994-12-20	1995-12-05	Elizabeth Arden Co., Division Of Conopco, Inc.	Composition for enhancing lipid production in skin
MY118354A (en) *	1995-05-01	2004-10-30	Scarista Ltd	1,3-propane diol derivatives as bioactive compounds
EP1021177A4 (de) *	1997-02-04	2002-05-15	John V Kosbab	Zusammensetzungen und verfahren zur verhütung und behandlung von vaskulär-degeneratieve krankheiten
IT1291113B1 (it) *	1997-03-20	1998-12-29	Sigma Tau Ind Farmaceuti	Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6048846A (en) *	1998-02-26	2000-04-11	Cochran; Timothy M.	Compositions used in human treatment

1997
- 1997-07-22 GB GB9715444A patent/GB9715444D0/en active Pending
1998
- 1998-07-21 ZA ZA986480A patent/ZA986480B/xx unknown
- 1998-07-22 AU AU84519/98A patent/AU739876B2/en not_active Ceased
- 1998-07-22 DE DE69822832T patent/DE69822832T2/de not_active Expired - Lifetime
- 1998-07-22 CN CNA2005100095125A patent/CN1679532A/zh active Pending
- 1998-07-22 PL PL98338219A patent/PL194059B1/pl unknown
- 1998-07-22 RU RU2000104121/14A patent/RU2205004C2/ru not_active IP Right Cessation
- 1998-07-22 EP EP03027639A patent/EP1419769A1/de not_active Withdrawn
- 1998-07-22 PT PT98935163T patent/PT994705E/pt unknown
- 1998-07-22 CA CA002297082A patent/CA2297082C/en not_active Expired - Fee Related
- 1998-07-22 SK SK84-2000A patent/SK285836B6/sk not_active IP Right Cessation
- 1998-07-22 CN CNB988075504A patent/CN1198608C/zh not_active Expired - Fee Related
- 1998-07-22 EP EP98935163A patent/EP0994705B1/de not_active Expired - Lifetime
- 1998-07-22 JP JP2000503839A patent/JP4476479B2/ja not_active Expired - Fee Related
- 1998-07-22 AT AT98935163T patent/ATE262900T1/de not_active IP Right Cessation
- 1998-07-22 HU HU0002701A patent/HU226673B1/hu not_active IP Right Cessation
- 1998-07-22 RO ROA200000052A patent/RO121318B1/ro unknown
- 1998-07-22 KR KR1020007000719A patent/KR100545630B1/ko not_active Expired - Fee Related
- 1998-07-22 US US09/463,300 patent/US6630157B1/en not_active Expired - Lifetime
- 1998-07-22 IL IL13409098A patent/IL134090A0/xx active IP Right Grant
- 1998-07-22 MY MYPI98003347A patent/MY127930A/en unknown
- 1998-07-22 TR TR2000/00178T patent/TR200000178T2/xx unknown
- 1998-07-22 CZ CZ20000229A patent/CZ298527B6/cs not_active IP Right Cessation
- 1998-07-22 TW TW087111948A patent/TW565444B/zh not_active IP Right Cessation
- 1998-07-22 BR BR9812102-2A patent/BR9812102A/pt not_active Application Discontinuation
- 1998-07-22 UA UA2000010521A patent/UA66363C2/uk unknown
- 1998-07-22 NZ NZ502278A patent/NZ502278A/en not_active IP Right Cessation
- 1998-07-22 ES ES98935163T patent/ES2214717T3/es not_active Expired - Lifetime
- 1998-07-22 DK DK98935163T patent/DK0994705T3/da active
- 1998-07-22 WO PCT/GB1998/002155 patent/WO1999004782A1/en not_active Ceased
- 1998-07-22 GB GB9816020A patent/GB2327347B/en not_active Revoked
2000
- 2000-01-17 IL IL134090A patent/IL134090A/en not_active IP Right Cessation
- 2000-01-21 NO NO20000303A patent/NO327173B1/no not_active IP Right Cessation
- 2000-02-08 BG BG104141A patent/BG64349B1/bg unknown

Also Published As

Publication number	Publication date
BG64349B1 (bg)	2004-11-30
TW565444B (en)	2003-12-11
HK1029281A1 (en)	2001-03-30
CA2297082A1 (en)	1999-02-04
RO121318B1 (ro)	2007-03-30
TR200000178T2 (tr)	2000-08-21
CZ2000229A3 (en)	2001-05-16
BR9812102A (pt)	2000-07-18
UA66363C2 (uk)	2004-05-17
HUP0002701A1 (hu)	2001-01-29
JP4476479B2 (ja)	2010-06-09
WO1999004782A1 (en)	1999-02-04
PL338219A1 (en)	2000-10-09
JP2001510799A (ja)	2001-08-07
KR20010022148A (ko)	2001-03-15
GB9816020D0 (en)	1998-09-23
RU2205004C2 (ru)	2003-05-27
DE69822832D1 (de)	2004-05-06
SK285836B6 (sk)	2007-09-06
KR100545630B1 (ko)	2006-01-24
CN1679532A (zh)	2005-10-12
EP1419769A1 (de)	2004-05-19
GB9715444D0 (en)	1997-09-24
AU739876B2 (en)	2001-10-25
CN1198608C (zh)	2005-04-27
NO20000303L (no)	2000-03-16
NO20000303D0 (no)	2000-01-21
NZ502278A (en)	2002-02-01
CZ298527B6 (cs)	2007-10-24
BG104141A (bg)	2000-10-31
CN1265032A (zh)	2000-08-30
IL134090A0 (en)	2001-04-30
HUP0002701A3 (en)	2001-03-28
ATE262900T1 (de)	2004-04-15
US6630157B1 (en)	2003-10-07
ES2214717T3 (es)	2004-09-16
PT994705E (pt)	2004-08-31
GB2327347A (en)	1999-01-27
DE69822832T2 (de)	2004-08-12
NO327173B1 (no)	2009-05-04
CA2297082C (en)	2008-04-22
DK0994705T3 (da)	2004-08-02
SK842000A3 (en)	2001-02-12
GB2327347B (en)	2000-10-04
EP0994705A1 (de)	2000-04-26
PL194059B1 (pl)	2007-04-30
MY127930A (en)	2006-12-29
IL134090A (en)	2006-08-20
EP0994705B1 (de)	2004-03-31
HU226673B1 (en)	2009-06-29
AU8451998A (en)	1999-02-16

Publication	Publication Date	Title
GB2327347B (en)	2000-10-04	Therapeutic and dietary compositions
IL150326A (en)	2005-06-19	Pediatric formula
IL143697A0 (en)	2002-04-21	Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
CA2231292A1 (en)	1999-03-19	Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
NZ516349A (en)	2004-03-26	Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
EP0211354A3 (de)	1988-02-10	Nukleoside und ihre Verwendung als antineoplastische Wirkstoffe
AU8970198A (en)	1999-03-22	N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in thetreatment of pain
IE890580L (en)	1989-08-24	Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
IL91184A0 (en)	1990-03-19	N-2,3-butadienyl tri-and tetraaminoalkane derivatives
WO1996015758A3 (en)	1996-07-11	Methods for stimulating erythropoiesis using thrombopoietin
AU6207196A (en)	1997-02-20	Composition and method for treating prostate cancer
AU2742395A (en)	1996-01-04	Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets
EP0190860A3 (de)	1987-06-03	6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepin-N-oxyd und dieses enthaltende Arzneimittel
UA39179C2 (uk)	2001-06-15	Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
SU1630043A1 (ru)	1994-02-28	Плазмозамещающий раствор для лечения шока "мафусол"
RU94004904A (ru)	1996-11-20	Средство для лечения лейкозов и способ лечения лейкозов
AU3992897A (en)	1998-04-09	Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
UA28900A (uk)	2000-10-16	Спосіб лікування хворих на хронічний гастрит зі збереженою і підвищеною секреторною та кислотоутворювальною функцією шлунка
BG101692A (en)	1999-06-30	Means for the prophylaxy and treatment of iodine-deficiency states
GR1002968B (el)	1998-09-09	Φαρμακευτικο παρασκευασμα βασιζομενο σε εναιωρημα εμβρυικων κυτταρων με ανοσοδιορθωτικη δραση και μεθοδος θεραπειας ζαχαρωδους διαβητη με τη χρηση αυτου του παρασκευασματος.
UA8273A (uk)	1996-03-29	Спосіб лікування опіків при багатофакторному пошкодженні
Glezer et al.	1985	Side effects of hypothiazide therapy of arterial hypertension.
AU5826886A (en)	1986-12-11	Carboxy azetidine derivatives for use in the reduction of blood cholesterol levels
AU5199286A (en)	1986-06-03	New use of 1,4-dihydropyridine derivatives
UA31177A (uk)	2000-12-15	Спосіб лікування нейросенсорної приглухуватості